Citadel Advisors »

Dexcom Inc Note 0.375 5/1 shares owned by Citadel Advisors

Quarter-by-quarter ownership of Dexcom Inc Note 0.375 5/1 shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Dexcom Inc Note 0.375 5/1

Tip: Access up to 7 years of quarterly data

All positions including Dexcom Inc Note 0.375 5/1 held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dexcom Inc Note 0.375 5/1 by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 27M 0.89

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Dexcom Inc Note 0.375 5/1

Advent Capital Management
Braidwell
Calamos Advisors
Franklin Resources
BlackRock
Hudson Bay Capital Management
Shenkman Capital Management
Wolverine Asset Management
Steelhead Partners
Bank of America Corporation
Citadel Advisors
State Street Corporation
Readystate Asset Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Dexcom Inc Note 0.375 5/1